NDC 16729-522
Pemetrexed
Pemetrexed Disodium
Pemetrexed is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Accord Healthcare Inc.. The primary component is Pemetrexed Disodium Hemipentahydrate.
| Product ID | 16729-522_e727befe-9df6-b48a-e053-2995a90acd8f |
| NDC | 16729-522 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pemetrexed |
| Generic Name | Pemetrexed Disodium |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-08-26 |
| Marketing Category | NDA / |
| Application Number | NDA214408 |
| Labeler Name | Accord Healthcare Inc. |
| Substance Name | PEMETREXED DISODIUM HEMIPENTAHYDRATE |
| Active Ingredient Strength | 25 mg/mL |
| Pharm Classes | Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |